We are live on ! Find out more
GH

Geisinger Health Portfolio holdings

AUM $344M
1-Year Est. Return 4.22%
This Fund
S&P 500
This Quarter Est. Return
+6.23%
1 Year Est. Return
+4.22%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$320M
AUM Growth
+$24.4M
Cap. Flow
+$5.86M
Cap. Flow %
1.83%
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
2
Reduced
2
Closed

Sector Composition

Rank Sector Weight
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGG icon
1
iShares Core US Aggregate Bond ETF
AGG
$138B
$175M 54.65%
1,759,432
+19,875
+1% +$1.89M
HYG icon
2
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$82.7M 25.88%
1,068,714
-28,828
-3% -$2.15M
IWB icon
3
iShares Russell 1000 ETF
IWB
$47.9B
$40.8M 12.75%
155,387
+655
+0.4% +$160K
EFV icon
4
iShares MSCI EAFE Value ETF
EFV
$28.5B
$13.4M 4.18%
256,500
-36,315
-12% -$1.8M
IEMG icon
5
iShares Core MSCI Emerging Markets ETF
IEMG
$147B
$8.09M 2.53%
+160,000
New +$7.75M

Similar funds

Geisinger Health's Q4 2023 Portfolio in Review

As of Q4 2023, Geisinger Health held 5 positions worth $320M, up 8.3% from $295M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Geisinger Health's Q4 2023 filing shows 1 new, 2 increased and 2 reduced positions. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 160,000 shares worth $8.09M. The largest sale was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $2.15M.

  • Geisinger Health's largest Q4 2023 buy was iShares Core MSCI Emerging Markets ETF: 160,000 shares worth $8.09M.
  • Geisinger Health added most to iShares Core US Aggregate Bond ETF in Q4 2023, an estimated $1.89M increase.
  • Geisinger Health's biggest Q4 2023 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $2.15M.
  • Geisinger Health's ten largest holdings make up 100% of its $320M portfolio in Q4 2023.
  • Geisinger Health opened 1 new position and closed 0 in Q4 2023.
  • Geisinger Health's portfolio value rose 8.3% quarter-over-quarter to $320M.

Based on Geisinger Health's 13F filing for Q4 2023, filed 13 Feb 2024.